Month: April 2022

Apr 23 2022

Uncategorized

FDA declines to move forward with schizophrenia treatment

by Clinical Editor

No Comments

The FDA has issued a Complete Response Letter for the New Drug Application for risperidone extended-release injectable for subcutaneous use, a schizophrenia treatment, Teva Pharmaceuticals and …

Apr 23 2022

Uncategorized

FDA Rejects Schizophrenia Tx; ADHD & Mental Health; Eating Disorder Treatment Scarce

by Clinical Editor

No Comments

The FDA hit Teva Pharmaceuticals and MedinCell with a complete response letter in regard to their new drug application for the schizophrenia treatment TV-46000/mdc-IRM (risperidone extended-release …

Apr 23 2022

Uncategorized

FDA delays approval for Teva schizophrenia drug

by Clinical Editor

No Comments

The approval of Teva Pharmaceutical Industries’ original treatment for schizophrenia has been delayed. Teva’s US unit Teva Pharmaceuticals and Me …

Apr 23 2022

Uncategorized

COVID and schizophrenia: Why this deadly mix can deepen knowledge of the brain disease

by Clinical Editor

No Comments

But sometimes they get loud and mean — like when a deadly pandemic descended on the world. “It’s when things go really, really fast and they seem overwhelmingly disastrous. That’s...

Apr 22 2022

Uncategorized

Schizophrenia: What Does It Really Feel Like? – Greatist

by Clinical Editor

No Comments

Schizophrenia: What Does It Really Feel Like?  Greatist Schizophrenia Spectrum Disorder: Symptoms and Related Conditions  Healthline Residual Schizophrenia Defined  Healthgrades OCD and Schizophrenia: What’s the Link?  PsychCentral.com Neurobiology of Schizophrenia: A Comprehensive Review  Cureus View...

Apr 22 2022

Uncategorized

FDA Rejects Schizophrenia Tx; ADHD & Mental Health; Eating Disorder Treatment Scarce

by Clinical Editor

No Comments

The FDA hit Teva Pharmaceuticals and MedinCell with a complete response letter in regard to their new drug application for the schizophrenia treatment TV-46000/mdc-IRM (risperidone extended-release …

Apr 22 2022

Uncategorized

Study finds genetic link to schizophrenia

by Clinical Editor

No Comments

Neurons in the central nervous system expressed schizophrenia, but no other cells or tissues did, Cardiff scientists find …

Apr 22 2022

Uncategorized

FDA declines to move forward with schizophrenia treatment

by Clinical Editor

No Comments

The FDA has issued a Complete Response Letter for the New Drug Application for risperidone extended-release injectable for subcutaneous use, a schizophrenia treatment, Teva Pharmaceuticals and …

Apr 22 2022

Uncategorized

COVID and schizophrenia: Why this deadly mix can deepen knowledge of the brain disease

by Clinical Editor

No Comments

But sometimes they get loud and mean — like when a deadly pandemic descended on the world. “It’s when things go really, really fast and they seem overwhelmingly disastrous. That’s...

Apr 22 2022

Uncategorized

Teva’s long-acting schizophrenia drug rejected by FDA

by Clinical Editor

No Comments

Setback for Teva and French partner MedinCell as FDA turns down marketing application for long-acting schizophrenia injectable TV-46000 …